The Impact of Dietary Unsaturated Fat or the Mediterranean Diet on Women Diagnosed With Breast Cancer: A Systematic Review.

anti-inflammatory diet antioxidants breast cancer cancer survival mediterranean diet omega-3 fatty acids plant-based diet polyunsaturated fatty acids quality of life unsaturated fats

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 27 06 2024
accepted: 22 07 2024
medline: 26 8 2024
pubmed: 26 8 2024
entrez: 26 8 2024
Statut: epublish

Résumé

This review explores the multifaceted relationship between dietary factors and breast cancer outcomes, focusing on unsaturated fats, the Mediterranean diet (MD), and other nutritional components. Breast cancer remains a significant global health concern, with lifestyle factors like diet playing a pivotal role in prevention and management. The review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Articles written in English and released between 2019 and 2024 were acceptable. We used pertinent search terms such as "unsaturated fats", "Mediterranean diet", "breast cancer", and "nutrition" to perform searches in PubMed, PubMed Central (PMC), EBSCOhost, and grey literature such as Google Scholar. After screening, 11 of the 479 original papers were chosen and included in the final review. These include cross-sectional analysis and systematic review, cohort study, narrative review, systematic review and meta-analysis, case-control study, randomized controlled trials (RCTs), and cross-sectional study. Key findings suggest that adherence to the MD correlates with improved quality of life measures and reduced mortality rates among women with breast cancer, particularly in older age groups. The diet's emphasis on antioxidant-rich foods, anti-inflammatory compounds, and healthy fats contributes to these observed benefits. Specific unsaturated fats, notably omega-3 polyunsaturated fatty acids (PUFAs) like docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), demonstrate anti-cancer properties by modulating cancer cell behavior and enhancing treatment responses. Biomarkers associated with the MD, such as β-carotene and lycopene, serve as indicators of dietary compliance and potential risk reduction. Furthermore, components found in olive oil, including polyphenols and monounsaturated fatty acids, exhibit promising effects in preventing breast cancer by exerting antioxidant and anti-proliferative actions. Other dietary factors like calcium, legumes, fruits, and vegetables also play a role in reducing breast cancer risk and improving survival rates. This review underscores the importance of dietary interventions in optimizing outcomes for breast cancer patients and highlights the need for further research to elucidate underlying mechanisms and refine dietary recommendations.

Identifiants

pubmed: 39184716
doi: 10.7759/cureus.65362
pmc: PMC11344571
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e65362

Informations de copyright

Copyright © 2024, Virani et al.

Déclaration de conflit d'intérêts

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Shikha Virani (S)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Sumayya Afreen (S)

Medicine, Deccan College of Medical Sciences, Hyderabad, IND.
Obstetrics and Gynecology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Arvin Perthiani (A)

General Surgery, Our Lady of Lourdes Hospital, Louth, IRL.

Elizabeth Sangster (E)

Medicine, Saint George's University, St. George, GRD.
Psychiatry and Behavioral Sciences, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Nidhi Lanka (N)

General Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Prakash Acharya (P)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Ann K Yu (AK)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Classifications MeSH